- Home
- RGNX vs DCGO Comparison
RGNX vs DCGO Comparison
Compare RGNX & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- DCGO
- Stock Information
- Founded
- RGNX 2008
- DCGO 2015
- Country
- RGNX United States
- DCGO United States
- Employees
- RGNX N/A
- DCGO N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- DCGO Managed Health Care
- Sector
- RGNX Health Care
- DCGO Health Care
- Exchange
- RGNX Nasdaq
- DCGO Nasdaq
- Market Cap
- RGNX 459.1M
- DCGO 417.4M
- IPO Year
- RGNX 2015
- DCGO N/A
- Fundamental
- Price
- RGNX $9.18
- DCGO $4.12
- Analyst Decision
- RGNX Strong Buy
- DCGO Strong Buy
- Analyst Count
- RGNX 12
- DCGO 5
- Target Price
- RGNX $36.36
- DCGO $6.10
- AVG Volume (30 Days)
- RGNX 886.8K
- DCGO 730.0K
- Earning Date
- RGNX 11-06-2024
- DCGO 11-07-2024
- Dividend Yield
- RGNX N/A
- DCGO N/A
- EPS Growth
- RGNX N/A
- DCGO 300.38
- EPS
- RGNX N/A
- DCGO 0.29
- Revenue
- RGNX $84,327,000.00
- DCGO $694,968,328.00
- Revenue This Year
- RGNX $7.91
- DCGO $1.17
- Revenue Next Year
- RGNX $214.75
- DCGO N/A
- P/E Ratio
- RGNX N/A
- DCGO $14.44
- Revenue Growth
- RGNX N/A
- DCGO 30.19
- 52 Week Low
- RGNX $8.54
- DCGO $2.75
- 52 Week High
- RGNX $28.80
- DCGO $6.21
- Technical
- Relative Strength Index (RSI)
- RGNX 43.02
- DCGO 65.99
- Support Level
- RGNX $8.87
- DCGO $3.84
- Resistance Level
- RGNX $12.11
- DCGO $4.43
- Average True Range (ATR)
- RGNX 0.96
- DCGO 0.26
- MACD
- RGNX -0.05
- DCGO 0.02
- Stochastic Oscillator
- RGNX 17.17
- DCGO 71.63
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.